These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 25225739)

  • 1. Factors associated with subjective side-effects during clozapine treatment.
    Seppälä N; Leinonen E; Viikki M; Solismaa A; Nuolivirta T; Kampman O
    Nord J Psychiatry; 2015 Apr; 69(3):161-6. PubMed ID: 25225739
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship between plasma concentrations of clozapine and norclozapine and therapeutic response in patients with schizophrenia resistant to conventional neuroleptics.
    Spina E; Avenoso A; Facciolà G; Scordo MG; Ancione M; Madia AG; Ventimiglia A; Perucca E
    Psychopharmacology (Berl); 2000 Jan; 148(1):83-9. PubMed ID: 10663421
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence and nature of side effects during clozapine maintenance treatment and the relationship with clozapine dose and plasma concentration.
    Yusufi B; Mukherjee S; Flanagan R; Paton C; Dunn G; Page E; Barnes TR
    Int Clin Psychopharmacol; 2007 Jul; 22(4):238-43. PubMed ID: 17519648
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma ratio of clozapine to N-desmethylclozapine can predict cognitive performance in treatment-resistant psychotic patients.
    Molins C; Carceller-Sindreu M; Navarro H; Carmona C; Piñeiro M; Martínez E; Álvarez E; Portella MJ
    Psychiatry Res; 2017 Dec; 258():153-157. PubMed ID: 29024893
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A systematic review and meta-analysis of the association between clozapine and norclozapine serum levels and peripheral adverse drug reactions.
    Tan MSA; Honarparvar F; Falconer JR; Parekh HS; Pandey P; Siskind DJ
    Psychopharmacology (Berl); 2021 Mar; 238(3):615-637. PubMed ID: 33410989
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CYP1A2 polymorphism -1545C > T (rs2470890) is associated with increased side effects to clozapine.
    Viikki M; Kampman O; Seppälä N; Mononen N; Lehtimäki T; Leinonen E
    BMC Psychiatry; 2014 Feb; 14():50. PubMed ID: 24555493
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Glasgow antipsychotic side-effects scale for clozapine in inpatients and outpatients with schizophrenia or schizoaffective disorder.
    Ignjatović Ristić D; Cohen D; Obradović A; Nikić-Đuričić K; Drašković M; Hinić D
    Nord J Psychiatry; 2018 Feb; 72(2):124-129. PubMed ID: 29125018
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Smoking and weight among patients using clozapine.
    Seppälä N; Leinonen E; Viikki M; Kampman O
    Nord J Psychiatry; 2014 Nov; 68(8):620-5. PubMed ID: 24802120
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dried Blood Spot Analysis for Therapeutic Drug Monitoring of Clozapine.
    Geers LM; Cohen D; Wehkamp LM; van Hateren K; Koster RA; Fedorenko OY; Semke AV; Bokhan N; Ivanova SA; Kosterink JGW; Loonen AJM; Touw DJ
    J Clin Psychiatry; 2017; 78(9):e1211-e1218. PubMed ID: 29068609
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum concentrations of clozapine and norclozapine in the prediction of relapse of patients with schizophrenia.
    Xiang YQ; Zhang ZJ; Weng YZ; Zhai YM; Li WB; Cai ZJ; Tan QR; Wang CY
    Schizophr Res; 2006 Apr; 83(2-3):201-10. PubMed ID: 16524698
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Retrospective evaluation of therapeutic drug monitoring of clozapine and norclozapine in Belgium using a multidrug UHPLC-MS/MS method.
    Patteet L; Maudens KE; Vermeulen Z; Dockx G; De Doncker M; Morrens M; Sabbe B; Neels H
    Clin Biochem; 2014 Dec; 47(18):336-9. PubMed ID: 25289972
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CYP1A2 activity as measured by a caffeine test predicts clozapine and active metabolite steady-state concentrationin patients with schizophrenia.
    Ozdemir V; Kalow W; Posner P; Collins EJ; Kennedy JL; Tang BK; Albers LJ; Reist C; Roy R; Walkes W; Afra P
    J Clin Psychopharmacol; 2001 Aug; 21(4):398-407. PubMed ID: 11476124
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intra-individual variation of clozapine and norclozapine plasma levels in clinical practice.
    Turrion MC; Perez J; Bernardo M; Fernandez-Egea E
    Rev Psiquiatr Salud Ment (Engl Ed); 2020; 13(1):31-35. PubMed ID: 31122757
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Once-daily versus divided dosing regimens of clozapine: A cross-sectional study in Singapore.
    Yang Z; Takeuchi H; Yee JY; See YM; Tang C; Ng BT; Lee J
    Schizophr Res; 2024 Jun; 268():66-73. PubMed ID: 37833207
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical outcome and plasma levels of clozapine and norclozapine in drug-resistant schizophrenic patients.
    Mauri M; Volonteri LS; Fiorentini A; Invernizzi G; Nerini T; Baldi M; Bareggi SR
    Schizophr Res; 2004 Feb; 66(2-3):197-8. PubMed ID: 15061256
    [No Abstract]   [Full Text] [Related]  

  • 16. Concentrations in plasma clozapine levels in schizophrenic and schizoaffective patients.
    Iglesias García C; Iglesias Alonso A; Bobes J
    Rev Psiquiatr Salud Ment; 2017; 10(4):192-196. PubMed ID: 28844295
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Determination of clozapine in serum by radioreceptor assay versus high-performance liquid chromatography: possible detection of hydroxy-metabolites.
    Odou P; Frimat B; Fontaine B; Luyckx M; Brunet C; Robert H; Dine T; Gressier B; Cazin M; Cazin JC
    J Clin Pharm Ther; 1996 Oct; 21(5):337-42. PubMed ID: 9119916
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exploring low clozapine C/D ratios, inverted clozapine-norclozapine ratios and undetectable concentrations as measures of non-adherence in clozapine patients: A literature review and a case series of 17 patients from 3 studies.
    Ruan CJ; Olmos I; Ricciardi C; Schoretsanitis G; Vincent PD; Anıl Yağcıoğlu AE; Eap CB; Baptista T; Clark SR; Fernandez-Egea E; Kim SH; Lane HY; Leung J; Maroñas Amigo O; Motuca M; Every-Palmer S; Procyshyn RM; Rohde C; Suhas S; Schulte PFJ; Spina E; Takeuchi H; Verdoux H; Correll CU; Molden E; De Las Cuevas C; de Leon J
    Schizophr Res; 2024 Jun; 268():293-301. PubMed ID: 37487869
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Use of atypical antipsychotics in Charles Perrens psychiatric hospital (Bordeaux) analysis of prescribing practices for Amisulpride, Clozapine, Olanzapine and Risperidone].
    Bret P; Bonnet F; Bret MC; Jaffré A
    Encephale; 2002; 28(4):329-42. PubMed ID: 12232542
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potential Role of Patients' CYP3A-Status in Clozapine Pharmacokinetics.
    Tóth K; Csukly G; Sirok D; Belic A; Kiss Á; Háfra E; Déri M; Menus Á; Bitter I; Monostory K
    Int J Neuropsychopharmacol; 2017 Jul; 20(7):529-537. PubMed ID: 28340122
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.